Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activities
Growth Metrics
Income Statement
Others
Ratios

Acro Biomedical (ACBM) Other financing activities (2017 - 2025)

Acro Biomedical has reported Other financing activities over the past 3 years, most recently at $2315.0 for Q4 2025.

  • Quarterly results put Other financing activities at $2315.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $3077.0 (up 303.81% YoY), and the annual figure for FY2025 was $4600.0, changed.
  • Other financing activities for Q4 2025 was $2315.0 at Acro Biomedical, up from $762.0 in the prior quarter.
  • Over the last five years, Other financing activities for ACBM hit a ceiling of $2315.0 in Q4 2025 and a floor of $2315.0 in Q4 2025.